Hospital
Multicare Health System
Multicare Health System was paid $23.19M by Medicaid between Apr 2018 and Dec 2024, across 277 billing codes. Its largest line is 96361, Intravenous infusion, hydration; each additional hour — 21% of everything it billed.
33Billing provider infoMULTICARE HEALTH SYSTEM
COVINGTON, WA 98042
COVINGTON, WA 98042
33aNPI1326564071assigned 08/15/2017
33bProvider typeGeneral Acute Care Hospital
28Total paid$23.19M
24GClaims834,193
24DCodes billed277
24AFirst – last monthApr 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Washington
Rank by total paid#23 of 49
Median peer was paid$20.06M
This provider vs. median1.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official ROBERTSON, WILLIAM controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 49,754 | $1.63M | |
| 2019 | 114,168 | $3.39M | |
| 2020 | 109,575 | $3.01M | |
| 2021 | 133,308 | $3.31M | |
| 2022 | 140,218 | $4.11M | |
| 2023 | 151,867 | $4.10M | |
| 2024incomplete | 135,303 | $3.65M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 96361 | Intravenous infusion, hydration; each additional hour | 21% | 14,793 | 12,971 | $4.78M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 20% | 34,234 | 32,775 | $4.57M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 11% | 29,010 | 26,816 | $2.46M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 9.5% | 21,504 | 20,408 | $2.21M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 6.8% | 8,446 | 8,029 | $1.57M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3.3% | 6,280 | 6,149 | $761K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.4% | 3,728 | 3,595 | $564K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 2.0% | 3,405 | 3,307 | $459K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.3% | 3,661 | 3,462 | $292K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 1.2% | 3,245 | 3,096 | $274K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.1% | 1,456 | 1,417 | $265K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 1.1% | 1,153 | 1,017 | $254K |
265 more codes
| 71275 | Computed tomographic angiography, chest, with contrast material | 1.1% | 1,702 | $249K |
| 76830 | Ultrasound, transvaginal | <1% | 2,745 | $229K |
| 80053 | Comprehensive metabolic panel | <1% | 47,023 | $217K |
| 70496 | <1% | 1,114 | $209K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 2,903 | $195K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 6,081 | $184K |
| 76642 | <1% | 1,949 | $170K | |
| D2930 | Prefabricated stainless steel crown - primary tooth | <1% | 116 | $157K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 5,155 | $156K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 2,539 | $110K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 1,305 | $108K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 13,208 | $100K |
| 59025 | Fetal non-stress test | <1% | 642 | $92K |
| 36415 | Collection of venous blood by venipuncture | <1% | 32,305 | $92K |
| 76770 | <1% | 765 | $88K | |
| 12001 | <1% | 394 | $84K | |
| 87400 | <1% | 6,156 | $75K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 8,021 | $74K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 52,155 | $72K |
| 76801 | <1% | 1,697 | $70K | |
| 84484 | <1% | 15,280 | $70K | |
| 80061 | Lipid panel | <1% | 9,697 | $67K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 5,734 | $66K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 231 | $58K |
| D7140 | Extraction, erupted tooth or exposed root | <1% | 27 | $49K |
| 74018 | <1% | 1,988 | $45K | |
| 93971 | <1% | 487 | $43K | |
| 83605 | <1% | 6,719 | $39K | |
| 76536 | <1% | 427 | $39K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 23,458 | $37K |
| 73564 | <1% | 1,133 | $37K | |
| 73030 | <1% | 2,464 | $37K | |
| 73630 | <1% | 2,801 | $35K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 301 | $35K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 494 | $35K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 5,756 | $33K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 3,687 | $32K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 6,353 | $31K |
| 73610 | <1% | 2,534 | $30K | |
| 87040 | <1% | 4,547 | $30K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 2,009 | $29K |
| 77066 | Tomosynthesis, mammo | <1% | 997 | $29K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 6,119 | $28K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 1,126 | $26K |
| 73562 | <1% | 2,435 | $25K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 140 | $25K |
| 83880 | <1% | 3,982 | $24K | |
| 80050 | General health panel | <1% | 3,379 | $24K |
| 10060 | <1% | 114 | $22K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 17,156 | $22K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 2,533 | $22K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 7,629 | $22K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 939 | $21K |
| 70498 | <1% | 1,121 | $20K | |
| 82728 | <1% | 2,538 | $20K | |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | <1% | 13 | $20K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 183 | $19K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 11,851 | $18K |
| 72100 | <1% | 1,351 | $18K | |
| G0378 | Hospital observation service, per hour | <1% | 2,331 | $17K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 1,423 | $17K |
| 87420 | <1% | 1,547 | $17K | |
| 73502 | <1% | 1,079 | $17K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 20,791 | $17K |
| 84439 | <1% | 2,612 | $16K | |
| 12011 | <1% | 64 | $15K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 2,486 | $15K |
| 85379 | <1% | 3,357 | $15K | |
| 82247 | <1% | 1,847 | $15K | |
| 73110 | <1% | 1,651 | $15K | |
| 76870 | <1% | 164 | $14K | |
| 73130 | <1% | 1,794 | $13K | |
| 87505 | <1% | 244 | $13K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 353 | $13K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 1,651 | $13K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 1,382 | $13K |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | <1% | 369 | $13K |
| 84702 | <1% | 3,818 | $13K | |
| 87070 | <1% | 7,471 | $12K | |
| 87481 | <1% | 1,406 | $12K | |
| 70491 | <1% | 69 | $12K | |
| 77080 | <1% | 207 | $11K | |
| 36592 | <1% | 16,523 | $11K | |
| 71045 | Radiologic examination, chest; single view | <1% | 6,607 | $10K |
| 87631 | <1% | 536 | $10K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 2,440 | $10K |
| 82607 | <1% | 1,319 | $10K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 694 | $10K |
| 83550 | <1% | 2,131 | $10K | |
| 86803 | <1% | 1,712 | $9K | |
| 70486 | <1% | 191 | $9K | |
| 82570 | <1% | 2,095 | $9K | |
| 90715 | <1% | 546 | $9K | |
| 87430 | <1% | 6,005 | $9K | |
| 86140 | <1% | 3,954 | $8K | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 1,233 | $8K |
| 80143 | <1% | 2,165 | $8K | |
| 81001 | <1% | 19,776 | $8K | |
| D2392 | Resin-based composite - two surfaces, posterior, primary or permanent | <1% | 14 | $8K |
| 83540 | <1% | 2,251 | $8K | |
| 85027 | <1% | 2,295 | $7K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 738 | $7K |
| 73140 | <1% | 634 | $7K | |
| 86780 | <1% | 1,029 | $7K | |
| 84703 | <1% | 14,347 | $7K | |
| 73560 | <1% | 326 | $6K | |
| 97802 | <1% | 87 | $6K | |
| 83690 | <1% | 13,499 | $6K | |
| 84145 | <1% | 709 | $6K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 13,990 | $6K |
| 87186 | <1% | 3,473 | $6K | |
| 82248 | <1% | 1,544 | $6K | |
| 80055 | <1% | 998 | $6K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 2,796 | $5K |
| 87149 | <1% | 1,111 | $5K | |
| 81003 | <1% | 11,888 | $5K | |
| 85652 | <1% | 2,781 | $5K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 5,606 | $5K |
| 96376 | <1% | 4,920 | $5K | |
| 73080 | <1% | 368 | $5K | |
| D3220 | Therapeutic pulpotomy (excluding final restoration) - removal of pulp coronal to the dentinocemental junction | <1% | 75 | $4K |
| 86003 | <1% | 638 | $4K | |
| 80179 | <1% | 2,138 | $4K | |
| 87205 | <1% | 4,333 | $4K | |
| 83735 | <1% | 4,219 | $4K | |
| 82784 | <1% | 419 | $4K | |
| 97803 | <1% | 57 | $3K | |
| 82105 | <1% | 351 | $3K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 31 | $3K |
| 82043 | <1% | 1,257 | $3K | |
| 82950 | <1% | 872 | $3K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 13 | $3K |
| 87808 | <1% | 2,589 | $3K | |
| 84153 | <1% | 353 | $3K | |
| 80076 | <1% | 509 | $3K | |
| J0561 | Injection, penicillin g benzathine, 100,000 units | <1% | 40 | $2K |
| 82746 | <1% | 551 | $2K | |
| 85610 | <1% | 3,061 | $2K | |
| 77065 | Tomosynthesis, mammo | <1% | 85 | $2K |
| 73590 | <1% | 389 | $2K | |
| 87077 | <1% | 2,168 | $2K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 7,503 | $2K |
| 84550 | <1% | 847 | $2K | |
| 86364 | <1% | 256 | $2K | |
| 81025 | <1% | 3,765 | $2K | |
| 87081 | <1% | 770 | $2K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 14,552 | $2K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 12 | $2K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 12,584 | $2K |
| 36416 | <1% | 4,988 | $2K | |
| J2704 | Injection, propofol, 10 mg | <1% | 3,570 | $2K |
| 85014 | <1% | 515 | $2K | |
| 12002 | <1% | 12 | $1K | |
| 84146 | <1% | 121 | $1K | |
| 82550 | <1% | 1,056 | $1K | |
| 86480 | <1% | 68 | $1K | |
| 84403 | <1% | 127 | $1K | |
| 83001 | <1% | 127 | $1K | |
| 82785 | <1% | 114 | $1K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 4,998 | $967.46 |
| 84156 | <1% | 368 | $923.96 | |
| 83520 | <1% | 133 | $923.10 | |
| 72131 | <1% | 44 | $916.33 | |
| 73090 | <1% | 256 | $901.34 | |
| D1120 | Dental cleaning, child | <1% | 274 | $876.02 |
| 82962 | <1% | 2,084 | $870.18 | |
| D1206 | Topical application of fluoride varnish | <1% | 265 | $858.75 |
| 85730 | <1% | 1,536 | $858.09 | |
| 80074 | <1% | 130 | $779.18 | |
| 86900 | <1% | 1,151 | $756.20 | |
| 71101 | <1% | 101 | $750.99 | |
| 80305 | <1% | 475 | $715.34 | |
| 84100 | <1% | 419 | $700.60 | |
| 87510 | <1% | 52 | $688.97 | |
| A9585 | Injection, gadobutrol, 0.1 ml | <1% | 326 | $687.32 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 4,249 | $664.68 |
| 83970 | <1% | 29 | $651.22 | |
| 82947 | <1% | 266 | $646.50 | |
| 86850 | <1% | 633 | $632.17 | |
| 71250 | <1% | 17 | $579.83 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 789 | $554.08 |
| 84460 | <1% | 221 | $484.07 | |
| 84450 | <1% | 190 | $461.65 | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 100 | $453.98 |
| 87660 | <1% | 52 | $436.50 | |
| 86901 | <1% | 1,427 | $420.63 | |
| 72040 | <1% | 37 | $408.26 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 4,355 | $404.15 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 2,318 | $372.00 |
| 82077 | <1% | 2,462 | $330.07 | |
| 86706 | <1% | 64 | $323.02 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 5,350 | $305.85 |
| 87340 | <1% | 67 | $278.88 | |
| 82330 | <1% | 59 | $268.17 | |
| 87480 | <1% | 52 | $256.18 | |
| J8540 | Dexamethasone, oral, 0.25 mg | <1% | 1,906 | $246.34 |
| D1351 | Sealant - per tooth | <1% | 26 | $245.40 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 5,088 | $212.72 |
| 83002 | <1% | 17 | $210.15 | |
| 84481 | <1% | 36 | $193.58 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 3,863 | $190.35 |
| 82010 | <1% | 575 | $186.66 | |
| 86039 | <1% | 33 | $161.77 | |
| 86308 | <1% | 75 | $161.73 | |
| 99152 | <1% | 83 | $150.48 | |
| 83655 | <1% | 13 | $140.38 | |
| 88304 | <1% | 99 | $131.96 | |
| 87493 | <1% | 17 | $128.46 | |
| 83993 | <1% | 13 | $125.76 | |
| 86665 | <1% | 24 | $122.64 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 1,218 | $119.14 |
| 73660 | <1% | 13 | $113.27 | |
| 82274 | <1% | 14 | $112.55 | |
| 96367 | <1% | 29 | $111.11 | |
| 82951 | <1% | 14 | $109.86 | |
| A4649 | Surgical supply; miscellaneous | <1% | 962 | $102.82 |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | <1% | 934 | $96.45 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | <1% | 535 | $93.42 |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 535 | $90.45 |
| 74022 | <1% | 12 | $84.30 | |
| J1815 | Injection, insulin, per 5 units | <1% | 962 | $74.25 |
| 84425 | <1% | 13 | $64.71 | |
| 87338 | <1% | 12 | $64.70 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 1,755 | $60.26 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 1,313 | $58.98 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 2,238 | $55.01 |
| 85018 | <1% | 56 | $49.16 | |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | <1% | 414 | $47.15 |
| 82952 | <1% | 14 | $44.13 | |
| 87634 | <1% | 65 | $43.24 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 761 | $34.86 |
| 87184 | <1% | 26 | $27.24 | |
| J1630 | Injection, haloperidol, up to 5 mg | <1% | 275 | $14.34 |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 176 | $3.12 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 179 | $2.67 |
| A4648 | Tissue marker, implantable, any type, each | <1% | 16 | $2.36 |
| J1790 | Injection, droperidol, up to 5 mg | <1% | 134 | $2.29 |
| J3370 | Injection, vancomycin hcl, 500 mg | <1% | 240 | $0.83 |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 167 | $0.27 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | <1% | 25 | $0.23 |
| A4351 | Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, or silicone elastomer, etc.), each | 0% | 1,070 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 114 | $0.00 |
| J3360 | Injection, diazepam, up to 5 mg | 0% | 79 | $0.00 |
| J1836 | Injection, metronidazole, 10 mg | 0% | 23 | $0.00 |
| D0230 | Intraoral - periapical each additional radiographic image | 0% | 14 | $0.00 |
| J3480 | Injection, potassium chloride, per 2 meq | 0% | 73 | $0.00 |
| J3490 | Unclassified drugs | 0% | 38 | $0.00 |
| 86769 | 0% | 16 | $0.00 | |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 0% | 18 | $0.00 |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | 0% | 20 | $0.00 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 0% | 15 | $0.00 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 5,943 | $0.00 |
| J1171 | Injection, hydromorphone, 0.1 mg | 0% | 43 | $0.00 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 0% | 140 | $0.00 |
| 82805 | 0% | 108 | $0.00 | |
| 0225U | 0% | 159 | $0.00 | |
| D0220 | Intraoral - periapical first radiographic image | 0% | 14 | $0.00 |
| J1650 | Injection, enoxaparin sodium, 10 mg | 0% | 461 | $0.00 |
| 77062 | 0% | 168 | $0.00 | |
| 29125 | 0% | 12 | $0.00 | |
| J2004 | Injection, lidocaine hcl with epinephrine, 1 mg | 0% | 37 | $0.00 |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 0% | 32 | $0.00 |
| J0670 | Injection, mepivacaine hydrochloride, per 10 ml | 0% | 26 | $0.00 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 0% | 26 | $0.00 |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialROBERTSON, WILLIAM (CEO)
| Provider | Location | Paid |
|---|---|---|
| Multicare Health System | Tacoma, WA | $162.25M |
| Multicare Health System | Tacoma, WA | $108.54M |
| Yakima Valley Memorial Hospital Association | Yakima, WA | $103.54M |
| Multicare Health System | Puyallup, WA | $77.99M |
| Multicare Health System | Tacoma, WA | $75.17M |
| Greater Lakes Mental Health Foundation INC | Lakewood, WA | $55.95M |
| Multicare Health System | Spokane, WA | $55.23M |
| Multicare Health System | Auburn, WA | $31.02M |
| Multicare Health System | Spokane Valley, WA | $24.75M |
| Multicare Health System | Olympia, WA | $16.97M |
| Multicare Health System | Tacoma, WA | $11.14M |
| Multicare Health System | Auburn, WA | $7.42M |
| Multicare Health System | Tacoma, WA | $2.68M |
| Alliance for South Sound Health | Tacoma, WA | $2.46M |
| Capital Medical Center Physicians LLC | Olympia, WA | $1.75M |
| Multicare Health System | Tacoma, WA | $1.53M |
| Yakima Valley Memorial Hospital Association | Yakima, WA | $1.16M |
| Capital Medical Center Specialty Physicians, LLC | Olympia, WA | $987K |
| Yakima Urology at Memorial TR | Yakima, WA | $784K |
| Multicare Health System | Spokane, WA | $179K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.